Financing ·
Lifecore Biomedical, Inc. announced that holders of all 49,263 outstanding shares of Series A Redeemable Convertible…
LFCRLifecore Biomedical, Inc. de
Lifecore Biomedical, Inc. announced that holders of all 49,263 outstanding shares of Series A Redeemable Convertible Preferred Stock received redemption notices, requiring a total payment of approximately $52.1 million. The company must pay the redemption amounts 180 days after notice, with a deadline of December 28, 2026, and must obtain lender consent to facilitate the payments. Lifecore Biomedical, Inc. is a medical device and pharmaceutical manufacturing company.